Sponsor of the Day:
Jerkmate
https://www.biospace.com/press-releases/eylea-hd-aflibercept-approved-by-fda-as-first-and-only-injectable-anti-vegf-with-dosing-intervals-up-to-5-months-for-wet-age-related-macular-degeneration-wamd-and-diabetic-macular-edema-dme
EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing...
eyleaapprovedfdafirstinjectable
https://www.statnews.com/2026/02/17/ocular-therapeutix-axpaxli-wet-amd-treatment-compared-to-eylea-regeneron/
Ocular Therapeutix wet AMD drug Axpaxli tops Eylea in study | STAT
Feb 17, 2026 - Ocular now plans to apply for FDA approval, but whether doctors and insurers will favor its new drug is an open question.
ocular therapeutixwet amdstudy statdrugtops
https://www.healio.com/news/ophthalmology/20260403/fda-approves-eylea-hd-dosing-intervals-up-to-5-months-for-wet-amd-dme
FDA approves extension of Eylea HD dosing intervals
Apr 3, 2026 - The FDA approved an extension of dosing intervals for Eylea HD in patients with diabetic macular edema and wet age-related macular degeneration, Regeneron...
fda approvesextensioneyleahddosing